Skip to main content

Table 1 Demographic and clinical characteristics of the study population at baseline

From: An Emollient Containing Aquaphilus dolomiae Extract is Effective in the Management of Xerosis and Pruritus: An International, Real-World Study

  FAS
N = 5910
Demographics
 Gender, n (%) n = 5718
  Female 3507 (61.3)
  Male 2211 (38.7)
 Age (years) n = 5839
  Mean (SD) 30.6 (25.8)
  Median (min–max) 25 (0–97)
 Environment, n (%) n = 5762
  Urban 4812 (83.5)
  Rural 949 (16.5)
  Both 1 (0)
Clinical characteristics
 Duration of xerosis (months) n = 4936
  Mean (SD) 47.6 (89.0)
  Median (Q1–Q3) 12.0 (0888)
 Duration of pruritus n = 4908
  Mean SD 28.9 (68.8)
  Median (min–max) 3 (0–888)
 Underlying skin diseases, n (%)a n = 5862
 Skin disease, yes 5384 (91.8)
  Atopic dermatitis 3511 (65.2)
  Senile xerosis 679 (12.6)
  Prurigob 363 (6.7)
  Undetermined etiology 250 (4.6)
  Ichthyosis 233 (4.3)
  Psoriasis 203 (3.8)
  Scabies (pruritus after antiscabies treatment) 156 (2.9)
  Prurigo nodularis of Hyde 38 (0.7)
  Other pathology 636 (11.8)
 Underlying systemic diseases, n (%)a n = 5043
  Systemic disease, yes 610 (12.1)
  Diabetes mellitus 199 (3.9)
  Thyroid disease 170 (3.4)
  Renal insufficiency 64 (1.3)
  Hepatic disease 27 (0.5)
  Hematologic disease 25 (0.5)
  Other disease 273 (5.4)
 Concomitant treatments, n (%)a n = 5606
  Ongoing treatment prescription, yes 1198 (21.4)
  Topical treatments 1016 (18.1)
  Systemic treatments 787 (13.3)
  1. FAS full analysis set, N number of patients in the whole study population, n number of patients for which data was collected, SD standard deviation, Q1–Q3 interquartile range
  2. aPatients may have had more than one skin disease or systemic disease or may have been prescribed more than one concomitant treatment
  3. bPatients with prurigo had lesions that did not show the specific characteristics of prurigo nodularis of Hyde, and had no diagnosis of any other underlying skin or systemic disease known to be associated with these lesions